Acknowledgements

Contributors and funders

Osteoporosis Australia gratefully acknowledges the contribution of Catherine Shore-Lorenti in the Department of Medicine, The University of Melbourne, in performing the literature searches for this guideline.

The Writing Group wishes to acknowledge the expert contributions of Professor John Eisman AO to the guideline.

Funding for the development of this guideline was provided by Amgen Australia, Actavis Australia, Pfizer Australia and Servier Laboratories (Aust). The information and recommendations presented in this guideline are based entirely on critical appraisal of peer-reviewed published evidence by the Working Group and the clinical experience and expert opinion of Working Group members.